How much funding has Carmell raised?

Carmell has disclosed $6M raised across 4 rounds.

Where is Carmell headquartered?

Carmell is headquartered in Pittsburgh, US.

Carmell

OTC: XAGE

Pittsburgh, US · Founded 2021 · Delaware corporation

Healthtech

Founders & leadership

Rajiv S. ShuklaExecutive

Bryan CassadayExecutive

David AndersonNamed on SEC filing

Board

Patrick SturgeonBoard director

Scott FrischBoard director

Kendra Bracken-FergusonBoard director

Richard UptonBoard director

Gilles SpenlehauerBoard director

Kathryn GregoryBoard director

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 4 rounds · 2024–2026

▶$200KraisedMar 2026 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Rajiv S. ShuklaExecutive Officer, Director
Kathryn GregoryDirector
Janakiram AjjarapuExecutive Officer, Director
Patrick SturgeonDirector
Scott FrischDirector
Bryan CassadayExecutive Officer
Gilles SpenlehauerDirector
Richard UptonDirector

Offering amount: $200K
Amount sold: $200K
First sale: Mar 2026
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$975.5KraisedJan 2025 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Richard UptonDirector
Scott FrischDirector
Bryan CassadayExecutive Officer
Rajiv ShuklaExecutive Officer, Director
Kathryn GregoryDirector
Patrick SturgeonDirector
Gilles S. SpenlehauerDirector

Offering amount: $1.1M
Amount sold: $975.5K
First sale: Jan 2025
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.9MraisedJan 2025 · 14 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Scott FrischDirector
Kendra Bracken-FergusonExecutive Officer
Richard UptonDirector
Patrick SturgeonDirector
Gilles SpenlehauerDirector
Kathryn GregoryDirector
Rajiv S. ShuklaExecutive Officer, Director
Bryan CassadayExecutive Officer

Offering amount: $3.7M
Amount sold: $1.9M
Sales commissions: $127.9K
Placement agents: Arcadia Securities, LLC
First sale: Jan 2025
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3MraisedApr 2024 · 19 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Gilles SpenlehauerDirector
Kathryn GregoryDirector
Richard UptonDirector
Patrick SturgeonDirector
David AndersonDirector
Rajiv S. ShuklaExecutive Officer, Director

Offering amount: $3M
Amount sold: $3M
Sales commissions: $212.2K
Placement agents: Arcadia Securities, LLC
First sale: Apr 2024
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-outfinance.yahoo.com · Jan 2025

Carmell Therapeutics Raises $1.85M in Private Placement with Potential $3.7M Total Funding | CTCX Stock Newsstocktitan.net · Dec 2024

Pittsburgh Money Moves: Carmell Therapeutics' SPAC deal has closedtechnical.ly · Jul 2023

Carmell Therapeutics closes $4M Series B round of fundingprnewswire.com · Jul 2017

Pittsburgh-based Carmell Therapeutics Corp. nears close of funding round, plans larger one later this year to launch product overseas - Pittsburgh Business Timesbizjournals.com · Jun 2014

Carmell Therapeutics raises $2.4M for blood plasma medical devicesmedcitynews.com · Apr 2011

Frequently asked questions

How much funding has Carmell raised?: Carmell has disclosed $6M raised across 4 rounds.
Where is Carmell headquartered?: Carmell is headquartered in Pittsburgh, US.